Joel Greenblatt’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46M | Buy |
119,007
+79,193
| +199% | +$29.4M | 0.11% | 218 |
|
|
2026
Q1 | $11.7M | Sell |
39,814
-72,869
| -65% | -$23.9M | 0.04% | 647 |
|
|
2025
Q4 | $39.5M | Sell |
112,683
-4,724
| -4% | -$1.6M | 0.14% | 126 |
|
|
2025
Q3 | $37.9M | Buy |
117,407
+58,077
| +98% | +$18.1M | 0.17% | 88 |
|
|
2025
Q2 | $23.1M | Sell |
59,330
-11,406
| -16% | -$4.59M | 0.14% | 144 |
|
|
2025
Q1 | $30.8M | Buy |
70,736
+17,050
| +32% | +$6.84M | 0.26% | 22 |
|
|
2024
Q4 | $19.8M | Buy |
53,686
+27,033
| +101% | +$11.3M | 0.19% | 84 |
|
|
2024
Q3 | $13.9M | Buy |
26,653
+14,840
| +126% | +$7.93M | 0.14% | 165 |
|
|
2024
Q2 | $6.4M | Buy |
11,813
+8,023
| +212% | +$4.24M | 0.08% | 344 |
|
|
2024
Q1 | $1.97M | Sell |
3,790
-6,724
| -64% | -$3.34M | 0.03% | 655 |
|
|
2023
Q4 | $4.96M | Buy |
10,514
+415
| +4% | +$192K | 0.09% | 299 |
|
|
2023
Q3 | $4.4M | Buy |
10,099
+2,551
| +34% | +$1.16M | 0.09% | 310 |
|
|
2023
Q2 | $3.35M | Buy |
7,548
+1,039
| +16% | +$479K | 0.07% | 381 |
|
|
2023
Q1 | $2.99M | Buy |
6,509
+303
| +5% | +$144K | 0.07% | 372 |
|
|
2022
Q4 | $3.18M | Sell |
6,206
-14,429
| -70% | -$7.33M | 0.09% | 280 |
|
|
2022
Q3 | $9.37M | Sell |
20,635
-2,002
| -9% | -$958K | 0.28% | 51 |
|
|
2022
Q2 | $10.9M | Sell |
22,637
-3,054
| -12% | -$1.51M | 0.35% | 39 |
|
|
2022
Q1 | $12.6M | Sell |
25,691
-2,594
| -9% | -$1.19M | 0.39% | 32 |
|
|
2021
Q4 | $13.1M | Buy |
28,285
+9,058
| +47% | +$3.81M | 0.42% | 30 |
|
|
2021
Q3 | $7.17M | Sell |
19,227
-685
| -3% | -$260K | 0.29% | 82 |
|
|
2021
Q2 | $7.6M | Buy |
19,912
+7,633
| +62% | +$2.92M | 0.32% | 64 |
|
|
2021
Q1 | $4.41M | Sell |
12,279
-8,773
| -42% | -$2.82M | 0.2% | 149 |
|
|
2020
Q4 | $6.76M | Sell |
21,052
-16,651
| -44% | -$5.11M | 0.22% | 136 |
|
|
2020
Q3 | $10.1M | Sell |
37,703
-12,719
| -25% | -$3.42M | 0.33% | 77 |
|
|
2020
Q2 | $13.3M | Buy |
50,422
+41,873
| +490% | +$11.2M | 0.4% | 50 |
|
|
2020
Q1 | $1.94M | Buy |
8,549
+933
| +12% | +$254K | 0.05% | 412 |
|
|
2019
Q4 | $2.3M | Sell |
7,616
-66,264
| -90% | -$18.2M | 0.04% | 436 |
|
|
2019
Q3 | $17.7M | Buy |
73,880
+63,826
| +635% | +$17.5M | 0.31% | 86 |
|
|
2019
Q2 | $2.84M | Sell |
10,054
-5,891
| -37% | -$1.61M | 0.05% | 430 |
|
|
2019
Q1 | $4.58M | Sell |
15,945
-1,859
| -10% | -$538K | 0.07% | 357 |
|
|
2018
Q4 | $4.68M | Sell |
17,804
-45,795
| -72% | -$12.6M | 0.07% | 349 |
|
|
2018
Q3 | $17.4M | Buy |
63,599
+46,051
| +262% | +$12M | 0.24% | 129 |
|
|
2018
Q2 | $4.18M | Buy |
17,548
+12,885
| +276% | +$2.98M | 0.06% | 371 |
|
|
2018
Q1 | $1.02M | Sell |
4,663
-31,620
| -87% | -$7.43M | 0.01% | 607 |
|
|
2017
Q4 | $8.16M | Sell |
36,283
-1,530
| -4% | -$326K | 0.12% | 264 |
|
|
2017
Q3 | $7.18M | Buy |
37,813
+1,308
| +4% | +$249K | 0.11% | 292 |
|
|
2017
Q2 | $6.87M | Buy |
36,505
+3,107
| +9% | +$558K | 0.1% | 303 |
|
|
2017
Q1 | $5.52M | Buy |
33,398
+4,990
| +18% | +$794K | 0.07% | 370 |
|
|
2016
Q4 | $4.08M | Buy |
28,408
+9,104
| +47% | +$1.22M | 0.05% | 411 |
|
|
2016
Q3 | $2.42M | Sell |
19,304
-15,465
| -44% | -$2M | 0.03% | 466 |
|
|
2016
Q2 | $4.57M | Buy |
+34,769
| New | +$4.76M | 0.05% | 400 |
|
|
2016
Q1 | – | Sell |
-78,913
| Closed | -$11M | – | 999 |
|
|
2015
Q4 | $11M | Sell |
78,913
-838
| -1% | -$115K | 0.12% | 271 |
|
|
2015
Q3 | $11.2M | Buy |
79,751
+22,043
| +38% | +$3.31M | 0.11% | 276 |
|
|
2015
Q2 | $9.47M | Buy |
57,708
+51,791
| +875% | +$8.27M | 0.08% | 354 |
|
|
2015
Q1 | $914K | Sell |
5,917
-918
| -13% | -$131K | 0.01% | 616 |
|
|
2014
Q4 | $859K | Buy |
6,835
+488
| +8% | +$60.3K | 0.01% | 650 |
|
|
2014
Q3 | $759K | Buy |
6,347
+818
| +15% | +$93.8K | 0.01% | 679 |
|
|
2014
Q2 | $595K | Sell |
5,529
-3,598
| -39% | -$371K | 0.01% | 757 |
|
|
2014
Q1 | $909K | Buy |
9,127
+6,405
| +235% | +$579K | 0.01% | 672 |
|
|
2013
Q4 | $251K | Sell |
2,722
-115
| -4% | -$10.2K | 0.01% | 894 |
|
|
2013
Q3 | $237K | Hold |
2,837
| – | – | 0.01% | 836 |
|
|
2013
Q2 | $232K | Buy |
+2,837
| New | +$212K | 0.01% | 807 |
|
Other funds holding ELV
Joel Greenblatt's ELV Position: Q2 2026 in Review
Joel Greenblatt increased its Elevance Health (ELV) stake by 199% in Q2 2026, buying an estimated $29.4M and bringing the position to 119,007 shares worth $46M. The position accounts for 0.11% of the portfolio, ranked #218.
Joel Greenblatt first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Joel Greenblatt held 119,007 shares of Elevance Health worth $46M as of Q2 2026.
- Joel Greenblatt bought 79,193 Elevance Health shares in Q2 2026, an estimated $29.4M.
- Elevance Health made up 0.11% of Joel Greenblatt's portfolio in Q2 2026, its #218 holding.
- Joel Greenblatt first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.